Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,774.80 | 86.80 | 1.00% |
CAC 40 | 7,632.78 | 95.21 | 1.26% |
DAX 40 | 23,697.32 | 428.31 | 1.84% |
Dow JONES (US) | 42,581.78 | 374.96 | 0.89% |
FTSE 100 | 8,788.03 | 29.99 | 0.34% |
HKSE | 24,177.07 | 487.94 | 2.06% |
NASDAQ | 19,630.97 | 183.56 | 0.94% |
Nikkei 225 | 38,790.56 | 436.47 | 1.14% |
NZX 50 Index | 12,467.48 | 65.17 | -0.52% |
S&P 500 | 6,025.17 | 0.00 | 0.00% |
S&P/ASX 200 | 8,555.50 | 80.60 | 0.95% |
SSE Composite Index | 3,420.57 | 38.98 | 1.15% |